CB vs CUE · P/E 14, rev $59.40B vs rev $9.3M
Chubb Ltd (CB) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. CUE currently screens at market cap $59.5M.
Not investment advice. Open the CB and CUE stock pages for the full models.
Not investment advice.